Re: Topical Treatment for Acute Phase Peyronie鈥檚 Disease Utilizing a New Gel, H-100: A Randomized, Prospective, Placebo-Controlled Pilot StudyAllen D. Seftel
Twidwell J, Levine LA. Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study. Int J Impot Res. 2015; doi: 10.1038/ijir.2015.22. [Epub ahead of print]....
Peyronie's disease (PD) is a debilitating condition of the penis that leads to significant pain, erectile dysfunction, and emotional distress in men. PD is likely underreported due to lack of knowledge of the disease and the absence of well-established available treatments. Surgical treatment can...
Twidwell J, Levine LA. Topical treatment for acute phase Peyronie's disease utilizing a new gel, H-100: a randomized, prospective, placebo-controlled pilot study. Int J Impot Res. 2015; doi: 10.1038/ijir.2015.22. [Epub ahead of print]....
One or more calcium channel blocker agents serve as the primary active ingredient of the present compositions, with carrier agents facilitating non-invasive transdermal delivery of the calcium channel blocker(s) to sub-dermal disease sites.doi:US20010047037 A1W. Jerry Easterling...
Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie’s disease--a placebo-controlled pilot study. J Sex Med. 2007; 4 :477–484.Levine L. Comment on ``Topical verapamil HCL, topical trifluo- roperazine, and topical magnesium sulfate for...
Topical beta- aminopropionitrile in the treatment of Peyronie's disease. J Urol. 1983;129(4):746-748.Gelbard M, Lindner A, Chvapil M, Kaufman J. Topical beta-aminopropionitrile in the treatment of Peyronie´s disease. J Urol 1983;129(4):746-748....